Literature DB >> 27693000

High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.

Iryna Janssen1, Paul Cooper2, Katrin Gunka1, Maja Rupnik3, Daniela Wetzel1, Ortrud Zimmermann1, Uwe Groß4.   

Abstract

Since data about Clostridium difficile infection in sub-Saharan Africa are scarce, we determined its epidemiology and risk factors in a cross-sectional study in Eikwe, a rural community in Ghana. We tested stool samples from 176 hospitalized patients with diarrhoea and from 131 asymptomatic non-hospitalized individuals for C. difficile and some other enteric pathogens. The overall prevalence rate of C. difficile was 4.9% with ribotype 084 being predominant. With 75% of the isolates, a high rate of nontoxigenic strains was present in symptomatic patients, most of whom had no other identified enteric pathogens. All strains were susceptible against metronidazole and vancomycin, respectively. Data on lifestyle and medical history showed that age <5years (p=0.004), and use of ceftriaxone (p=0.023) were the most important risk factors for C. difficile carriage status. Although our data suggest that C. difficile is currently not a major cause of diarrhoea in this setting, the epidemiology of C. difficile in sub-Saharan Africa awaits further investigation. Copyright Â
© 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Africa; Clostridium difficile; Epidemiology; Nontoxigenic strain

Mesh:

Substances:

Year:  2016        PMID: 27693000     DOI: 10.1016/j.ijmm.2016.09.004

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  9 in total

Review 1.  Assessing the Burden of Clostridium difficile Infection in Low- and Middle-Income Countries.

Authors:  G A Roldan; A X Cui; N R Pollock
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

Review 2.  Clostridioides difficile phage biology and application.

Authors:  Joshua Heuler; Louis-Charles Fortier; Xingmin Sun
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

3.  Gut bacterial communities of diarrheic patients with indications of Clostridioides difficile infection.

Authors:  Dominik Schneider; Andrea Thürmer; Kathleen Gollnow; Raimond Lugert; Katrin Gunka; Uwe Groß; Rolf Daniel
Journal:  Sci Data       Date:  2017-10-17       Impact factor: 6.444

4.  Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study.

Authors:  Masoumeh Azimirad; Marcela Krutova; Abbas Yadegar; Shabnam Shahrokh; Meysam Olfatifar; Hamid Asadzadeh Aghdaei; Warren N Fawley; Mark H Wilcox; Mohammad Reza Zali
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

5.  Clostridioides difficile Activates Human Mucosal-Associated Invariant T Cells.

Authors:  Isabel Bernal; Julia Danielle Hofmann; Björn Bulitta; Frank Klawonn; Annika-Marisa Michel; Dieter Jahn; Meina Neumann-Schaal; Dunja Bruder; Lothar Jänsch
Journal:  Front Microbiol       Date:  2018-10-25       Impact factor: 5.640

6.  Prevalence and Strain Characterization of Clostridioides (Clostridium) difficile in Representative Regions of Germany, Ghana, Tanzania and Indonesia - A Comparative Multi-Center Cross-Sectional Study.

Authors:  Mwanaisha Seugendo; Iryna Janssen; Vanessa Lang; Irene Hasibuan; Wolfgang Bohne; Paul Cooper; Rolf Daniel; Katrin Gunka; R L Kusumawati; Stephen E Mshana; Lutz von Müller; Benard Okamo; Jan R Ortlepp; Jörg Overmann; Thomas Riedel; Maja Rupnik; Ortrud Zimmermann; Uwe Groß
Journal:  Front Microbiol       Date:  2018-08-07       Impact factor: 5.640

7.  Clostridioides difficile infection in the Asia-Pacific region.

Authors:  Deirdre A Collins; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Briony Elliott; Thomas V Riley; Kazuhiro Tateda
Journal:  Emerg Microbes Infect       Date:  2019-12-24       Impact factor: 7.163

8.  Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro.

Authors:  Masoumeh Azimirad; Maryam Noori; Fahimeh Azimirad; Fatemeh Gholami; Kaveh Naseri; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-09-26       Impact factor: 6.781

9.  High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya.

Authors:  Winnie C Mutai; Marianne W Mureithi; Omu Anzala; Gunturu Revathi; Brian Kullin; Magdaline Burugu; Cecilia Kyany'a; Erick Odoyo; Peter Otieno; Lillian Musila
Journal:  Front Cell Infect Microbiol       Date:  2021-02-08       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.